{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:39:08Z","timestamp":1792723148478,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":93,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32HL166141"],"award-info":[{"award-number":["T32HL166141"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01HL156655"],"award-info":[{"award-number":["U01HL156655"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01HL156655"],"award-info":[{"award-number":["U01HL156655"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U54HL185005"],"award-info":[{"award-number":["U54HL185005"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["SUN22F0"],"award-info":[{"award-number":["SUN22F0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030692","name":"Intramural Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Clinical Center Bench-to-Bedside program"],"award-info":[{"award-number":["Clinical Center Bench-to-Bedside program"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Clinical Center Bench-to-Bedside program"],"award-info":[{"award-number":["Clinical Center Bench-to-Bedside program"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>STAT3 hyper-IgE syndrome (STAT3-HIES), historically known as Job syndrome, is a rare primary immunodeficiency caused by dominant-negative mutations in STAT3. STAT3-HIES is characterized by impaired mucosal immunity, connective tissue abnormalities, and recurrent cutaneous and pulmonary infections. Although STAT3-dependent immune and epithelial pathways are central to airway host defense, the respiratory microbiome in STAT3-HIES remains poorly defined. To address this question, we profiled upper and lower respiratory tract microbiomes using 16S rDNA gene sequencing of oral rinse samples from eight STAT3-HIES participants and eight matched healthy controls, and bronchoalveolar lavage fluid (BALF) samples from eight STAT3-HIES participants and six healthy controls that passed sequencing quality thresholds. Oral rinse samples from STAT3-HIES participants showed lower phylogenetic diversity and significantly altered microbial community structure compared with controls. In BALF, \u03b1-diversity was comparable between groups, but \u03b2-diversity differed significantly, indicating altered lower airway microbial community composition in STAT3-HIES. Differential abundance analysis identified enrichment of the genus Rothia in STAT3-HIES BALF, and Rothia relative abundance positively correlated with BALF IL-1\u03b2, IL-1RA, and IL-8. Although limited by cohort size, these findings provide the first characterization of respiratory microbiome alterations in STAT3-HIES and suggest that impaired STAT3-dependent immune pathways may influence airway microbial ecology and inflammatory responses.<\/jats:p>","DOI":"10.1186\/s13023-026-04508-x","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T06:05:22Z","timestamp":1784700322000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Respiratory microbiome dysbiosis in STAT3 hyper-IgE syndrome (Job syndrome)"],"prefix":"10.1186","volume":"21","author":[{"given":"Cristian","family":"Roca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Greenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan T.","family":"Zorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra F.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Boucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth N.","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Wolfgang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"4508_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0168-9525(00)89000-9","volume":"11","author":"JN Ihle","year":"1995","unstructured":"Ihle JN, Kerr IM. Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet. 1995;11:69\u201374.","journal-title":"Trends Genet"},{"key":"4508_CR2","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1172\/JCI0215650","volume":"109","author":"DE Levy","year":"2002","unstructured":"Levy DE, Lee C. What does Stat3 do? J Clin Invest. 2002;109:1143\u20138.","journal-title":"J Clin Invest"},{"key":"4508_CR3","doi-asserted-by":"publisher","first-page":"e70152","DOI":"10.1002\/mco2.70152","volume":"6","author":"MA Samad","year":"2025","unstructured":"Samad MA, Ahmad I, Hasan A, Alhashmi MH, Ayub A, Al-Abbasi FA, et al. STAT3 signaling pathway in health and disease. MedComm. 2025;6:e70152.","journal-title":"MedComm"},{"key":"4508_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJMra1202117","volume":"368","author":"JJ O\u2019Shea","year":"2013","unstructured":"O\u2019Shea JJ, Holland SM, Staudt LM. JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med. 2013;368:161\u201370.","journal-title":"N Engl J Med"},{"key":"4508_CR5","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.jaci.2010.01.047","volume":"125","author":"DC Vinh","year":"2010","unstructured":"Vinh DC, Sugui JA, Hsu AP, Freeman AF, Holland SM. Invasive fungal disease in autosomal-dominant hyper-IgE syndrome. J Allergy Clin Immunol. 2010;125:1389\u201390.","journal-title":"J Allergy Clin Immunol"},{"key":"4508_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.05.001","volume":"31","author":"EJ Hillmer","year":"2016","unstructured":"Hillmer EJ, Zhang H, Li HS, Watowich SS. STAT3 signaling in immunity. Cytokine Growth Factor Rev. 2016;31:1\u201315.","journal-title":"Cytokine Growth Factor Rev"},{"key":"4508_CR7","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/nature06096","volume":"448","author":"Y Minegishi","year":"2007","unstructured":"Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007;448:1058\u201362.","journal-title":"Nature"},{"key":"4508_CR8","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1056\/NEJMc076367","volume":"357","author":"ED Renner","year":"2007","unstructured":"Renner ED, Torgerson TR, Rylaarsdam S, A\u00f1over-Sombke S, Golob K, LaFlam T, et al. STAT3 mutation in the original patient with Job\u2019s syndrome. N Engl J Med. 2007;357:1667\u20138.","journal-title":"N Engl J Med"},{"key":"4508_CR9","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.jaip.2017.06.041","volume":"6","author":"Y Gernez","year":"2018","unstructured":"Gernez Y, Freeman AF, Holland SM, Garabedian E, Patel NC, Puck JM, et al. Autosomal Dominant Hyper-IgE Syndrome in the USIDNET Registry. J Allergy Clin Immunol Pract. 2018;6:996\u20131001.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"4508_CR10","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/imcb.12209","volume":"97","author":"T Al-Shaikhly","year":"2019","unstructured":"Al-Shaikhly T, Ochs HD. Hyper IgE syndromes: clinical and molecular characteristics. Immunol Cell Biol. 2019;97:368\u201379.","journal-title":"Immunol Cell Biol"},{"key":"4508_CR11","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/NEJMoa073687","volume":"357","author":"SM Holland","year":"2007","unstructured":"Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007;357:1608\u201319.","journal-title":"N Engl J Med"},{"key":"4508_CR12","first-page":"tw113","volume":"2007","author":"JF Foley","year":"2007","unstructured":"Foley JF. STAT3 regulates the generation of th17 cells. Science\u2019s STKE. 2007;2007:tw113\u2013113.","journal-title":"Science\u2019s STKE"},{"key":"4508_CR13","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nature06764","volume":"452","author":"JD Milner","year":"2008","unstructured":"Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature. 2008;452:773\u20136.","journal-title":"Nature"},{"key":"4508_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jaci.2008.04.037","volume":"122","author":"ED Renner","year":"2008","unstructured":"Renner ED, Rylaarsdam S, Anover-Sombke S, Rack AL, Reichenbach J, Carey JC, et al. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol. 2008;122:181\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"4508_CR15","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nm1720","volume":"14","author":"Y Zheng","year":"2008","unstructured":"Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med. 2008;14:282\u20139.","journal-title":"Nat Med"},{"key":"4508_CR16","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s10875-021-01051-1","volume":"41","author":"C Tsilifis","year":"2021","unstructured":"Tsilifis C, Freeman AF, Gennery AR. STAT3 Hyper-IgE Syndrome-an Update and Unanswered Questions. J Clin Immunol. 2021;41:864\u201380.","journal-title":"J Clin Immunol"},{"key":"4508_CR17","doi-asserted-by":"crossref","unstructured":"Sun L, Walls SA, Dang H, Quinney NL, Sears PR, Sadritabrizi T, et al. STAT3-dependent regulation of CFTR and ciliogenesis is essential for mucociliary clearance and innate airway defense in Hyper-IgE syndrome. Am J Respir Crit Care Med. 2025;211(10):1951\u201369.","DOI":"10.1164\/rccm.202407-1415OC"},{"key":"4508_CR18","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41579-022-00821-x","volume":"21","author":"JG Natalini","year":"2023","unstructured":"Natalini JG, Singh S, Segal LN. The dynamic lung microbiome in health and disease. Nat Rev Microbiol. 2023;21:222\u201335.","journal-title":"Nat Rev Microbiol"},{"key":"4508_CR19","doi-asserted-by":"crossref","unstructured":"Richardson H, Dicker AJ, Barclay H, Chalmers JD. The microbiome in bronchiectasis. Eur Respir Rev. 2019;28.","DOI":"10.1183\/16000617.0048-2019"},{"key":"4508_CR20","doi-asserted-by":"publisher","first-page":"e1006798","DOI":"10.1371\/journal.ppat.1006798","volume":"14","author":"MS Muhlebach","year":"2018","unstructured":"Muhlebach MS, Zorn BT, Esther CR, Hatch JE, Murray CP, Turkovic L, et al. Initial acquisition and succession of the cystic fibrosis lung microbiome is associated with disease progression in infants and preschool children. PLoS Pathog. 2018;14:e1006798.","journal-title":"PLoS Pathog"},{"key":"4508_CR21","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jaci.2022.12.821","volume":"152","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Lin T, Leung HM, Zhang C, Wilson-Mifsud B, Feldman MB, et al. STAT3 mutation-associated airway epithelial defects in Job syndrome. J Allergy Clin Immunol. 2023;152:538\u201350.","journal-title":"J Allergy Clin Immunol"},{"key":"4508_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s13023-025-03749-6","volume":"20","author":"T Xie","year":"2025","unstructured":"Xie T, Xu N, Zhao H, Han Y, Wu J, Di H, et al. Pulmonary features and stage of disease in adult patients with hyper-IgE syndrome: a single-centre clinical study and literature review. Orphanet J Rare Dis. 2025;20:270.","journal-title":"Orphanet J Rare Dis"},{"key":"4508_CR23","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1101\/gr.159467.113","volume":"23","author":"J Oh","year":"2013","unstructured":"Oh J, Freeman AF, Comparative Sequencing NISC, Program, Park M, Sokolic R, Candotti F, et al. The altered landscape of the human skin microbiome in patients with primary immunodeficiencies. Genome Res. 2013;23:2103\u201314.","journal-title":"Genome Res"},{"key":"4508_CR24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000351912","volume":"6","author":"SP Smeekens","year":"2014","unstructured":"Smeekens SP, Huttenhower C, Riza A, van de Veerdonk FL, Zeeuwen PLJM, Schalkwijk J, et al. Skin microbiome imbalance in patients with STAT1\/STAT3 defects impairs innate host defense responses. J Innate Immun. 2014;6:253\u201362.","journal-title":"J Innate Immun"},{"key":"4508_CR25","doi-asserted-by":"crossref","unstructured":"Sharma M, Dhaliwal M, Tyagi R, Goyal T, Sharma S, Rawat A. Microbiome and its dysbiosis in inborn errors of immunity. Pathogens. 2023;12.","DOI":"10.3390\/pathogens12040518"},{"key":"4508_CR26","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.jaci.2023.07.010","volume":"152","author":"E Guttman-Yassky","year":"2023","unstructured":"Guttman-Yassky E, Irvine AD, Brunner PM, Kim BS, Boguniewicz M, Parmentier J, et al. The role of Janus kinase signaling in the pathology of atopic dermatitis. J Allergy Clin Immunol. 2023;152:1394\u2013404.","journal-title":"J Allergy Clin Immunol"},{"key":"4508_CR27","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s40168-018-0605-2","volume":"6","author":"NM Davis","year":"2018","unstructured":"Davis NM, Proctor DM, Holmes SP, Relman DA, Callahan BJ. Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data. Microbiome. 2018;6:226.","journal-title":"Microbiome"},{"key":"4508_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.mimet.2016.09.002","volume":"130","author":"A Hahn","year":"2016","unstructured":"Hahn A, Sanyal A, Perez GF, Colberg-Poley AM, Campos J, Rose MC, et al. Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum. J Microbiol Methods. 2016;130:95\u20139.","journal-title":"J Microbiol Methods"},{"key":"4508_CR29","doi-asserted-by":"publisher","first-page":"baq013","DOI":"10.1093\/database\/baq013","volume":"2010","author":"T Chen","year":"2010","unstructured":"Chen T, Yu W-H, Izard J, Baranova OV, Lakshmanan A, Dewhirst FE. The Human Oral Microbiome Database: a web accessible resource for investigating oral microbe taxonomic and genomic information. Database (Oxford). 2010;2010:baq013.","journal-title":"Database (Oxford)"},{"key":"4508_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41592-023-02092-7","volume":"21","author":"H Lin","year":"2024","unstructured":"Lin H, Peddada SD. Multigroup analysis of compositions of microbiomes with covariate adjustments and repeated measures. Nat Methods. 2024;21:83\u201391.","journal-title":"Nat Methods"},{"key":"4508_CR31","doi-asserted-by":"crossref","unstructured":"Abusleme L, Diaz PI, Freeman AF, Greenwell-Wild T, Brenchley L, Desai JV et al. Human defects in STAT3 promote oral mucosal fungal and bacterial dysbiosis. JCI Insight. 2018;3.","DOI":"10.1172\/jci.insight.122061"},{"key":"4508_CR32","doi-asserted-by":"publisher","first-page":"782825","DOI":"10.3389\/fmicb.2022.782825","volume":"13","author":"M Dinis","year":"2022","unstructured":"Dinis M, Agnello M, Cen L, Shokeen B, He X, Shi W, et al. Oral Microbiome: Streptococcus mutans\/Caries Concordant-Discordant Children. Front Microbiol. 2022;13:782825.","journal-title":"Front Microbiol"},{"key":"4508_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.oooo.2012.04.005","volume":"114","author":"L Esposito","year":"2012","unstructured":"Esposito L, Poletti L, Maspero C, Porro A, Pietrogrande MC, Pavesi P, et al. Hyper-IgE syndrome: dental implications. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:147\u201353.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"4508_CR34","doi-asserted-by":"publisher","first-page":"9358","DOI":"10.1074\/jbc.C600321200","volume":"282","author":"XO Yang","year":"2007","unstructured":"Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, Watowich SS, et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem. 2007;282:9358\u201363.","journal-title":"J Biol Chem"},{"key":"4508_CR35","doi-asserted-by":"publisher","first-page":"e258283","DOI":"10.1001\/jamanetworkopen.2025.8283","volume":"8","author":"AK Chaturvedi","year":"2025","unstructured":"Chaturvedi AK, Vogtmann E, Shi J, Yano Y, Blaser MJ, Bokulich NA, et al. Oral microbiome profile of the US population. JAMA Netw Open. 2025;8:e258283.","journal-title":"JAMA Netw Open"},{"key":"4508_CR36","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.tim.2024.03.009","volume":"32","author":"SR West","year":"2024","unstructured":"West SR, Suddaby AB, Lewin GR, Ibberson CB. Rothia Trends Microbiol. 2024;32:720\u20131.","journal-title":"Rothia Trends Microbiol"},{"key":"4508_CR37","doi-asserted-by":"crossref","unstructured":"Rigauts C, Aizawa J, Taylor SL, Rogers GB, Govaerts M, Cos P, et al. Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease. Eur Respir J. 2022;59.","DOI":"10.1183\/13993003.01293-2021"},{"key":"4508_CR38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jmii.2024.11.011","volume":"58","author":"T-Y Yen","year":"2025","unstructured":"Yen T-Y, Hsu C, Lee N-C, Wu C-S, Wang H, Lee K-Y, et al. Signatures of lower respiratory tract microbiome in children with severe community-acquired pneumonia using shotgun metagenomic sequencing. J Microbiol Immunol Infect. 2025;58:86\u201393.","journal-title":"J Microbiol Immunol Infect"},{"key":"4508_CR39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3109\/00365548.2014.980843","volume":"47","author":"S Maraki","year":"2015","unstructured":"Maraki S, Papadakis IS. Rothia mucilaginosa pneumonia: a literature review. Infect Dis (Lond). 2015;47:125\u20139.","journal-title":"Infect Dis (Lond)"},{"key":"4508_CR40","doi-asserted-by":"publisher","first-page":"e0843","DOI":"10.1002\/rcr2.843","volume":"9","author":"K Sonehara","year":"2021","unstructured":"Sonehara K, Araki T, Hanaoka M. Rothia aeria pneumonia in an immunocompetent patient: A novel case study. Respirol Case Rep. 2021;9:e0843.","journal-title":"Respirol Case Rep"},{"key":"4508_CR41","doi-asserted-by":"crossref","unstructured":"Gao B, Gallagher T, Zhang Y, Elbadawi-Sidhu M, Lai Z, Fiehn O, et al. Tracking polymicrobial metabolism in cystic fibrosis airways: Pseudomonas aeruginosa metabolism and physiology are influenced by Rothia mucilaginosa-derived metabolites. mSphere. 2018;3.","DOI":"10.1128\/mSphere.00151-18"},{"key":"4508_CR42","doi-asserted-by":"publisher","first-page":"1176044","DOI":"10.3389\/fimmu.2023.1176044","volume":"14","author":"E Goeteyn","year":"2023","unstructured":"Goeteyn E, Grassi L, Van den Bossche S, Rigauts C, Vande Weygaerde Y, Van Braeckel E, et al. Commensal bacteria of the lung microbiota synergistically inhibit inflammation in a three-dimensional epithelial cell model. Front Immunol. 2023;14:1176044.","journal-title":"Front Immunol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04508-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04508-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04508-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:07:51Z","timestamp":1792721271000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04508-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4508"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04508-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of the National Heart, Lung, and Blood Institute (NHLBI), IRB# 07-H-0142. The study was conducted in accordance with the Declaration of Helsinki and applicable U.S. federal regulations for the protection of human subjects and the ethical principles underlying human subject research. STAT3-HIES and healthy control volunteers were recruited at the NHLBI (Bethesda, MD) between March 2017 and July 2018. All participants met predefined inclusion and exclusion criteria and provided written informed consent prior to enrollment.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"370"}}